Skip to Content
Merck
CN

I17002

Interleukin-2 human

IL-2, recombinant, expressed in HEK 293 cells, suitable for cell culture, endotoxin tested

Synonym(s):

Interleukin-2 human, Interleukin-2, T-cell growth factor

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352202
NACRES:
NA.77
MDL number:
Form:
lyophilized powder
Assay:
≥98% (SDS-PAGE)
Recombinant:
expressed in HEK 293 cells
Mol wt:
15 kDa (glycosylated)
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


recombinant

expressed in HEK 293 cells

assay

≥98% (SDS-PAGE)

form

lyophilized powder

potency

≤4 ng/mL ED50

mol wt

15 kDa (glycosylated)

technique(s)

cell culture | mammalian: suitable

suitability

endotoxin tested

storage temp.

−20°C

General description

Interleukin-2 (IL-2) is an immunomodulatory factor produced by certain subsets of T lymphocytes. It is a monomeric glycoprotein and proinflammatory cytokine, and contains four-a-helix bundles in its structure. IL-2 gene is mapped to human chromosome 4q27. Recombinant human IL-2 is expressed in human 293 cells as a glycoprotein with a calculated molecular mass of 15 kDa. This protein is manufactured in human cells using an all-human production system, with full chemically defined ingredients and with no serum. The human cells expression system allows human-like glycosylation and folding, and often supports better stability of the protein in culture.

Biochem/physiol Actions

Interleukin-2 (IL-2) is a lymphokine that promotes the long-term proliferation of activated T cells and acts as an essential mediator of the immune response. IL-2 signals through the IL-2 receptor, majorly via the IL-2Ra subunit. IL-2 signaling via IL-2/anti-IL-2 immune complexes aids immune surveillance improvement during suppressed immunity. It also effectively controls infection. IL-2 plays a role in the activation and proliferation of natural killer (NK) cells, induces γ-inter-feron and B cell growth factor secretion and modulates the expression of the IL-2 receptor. It also elicits anti-tumor immunity. An elevated expression level of IL-2 along with other interleukins is observed in colorectal cancer.
Interleukin-2 (IL-2) is an immunomodulatory factor produced by certain subsets of T lymphocytes. This lympho­kine promotes long term growth of acti­vated T cells and related cell types. IL-2 plays a role in the activation and proliferation of NK cells, induces γ-inter­feron and B cell growth factor secretion, and modulates the expression of the IL-2 receptor.

Physical form

Supplied as a lyophilized powder containing phosphate buffered saline.

Analysis Note

The biological activity of recombinant human IL-2 was tested in culture by measuring its ability to stimulate proliferation of the mouse CTLL-2 cells (mouse cytotoxic T cell line).

Other Notes

APTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT


Still not finding the right product?

Explore all of our products under Interleukin-2 human


hcodes

Hazard Classifications

Aquatic Chronic 3

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Related Content


T D Santos et al.
Pathologica, 111(2), 62-66 (2019-08-08)
There is a need for the development of new biomarkers for diagnosis and prognosis of ovarian cancer, which can ideally serve as targets for new therapeutic modalities and individualization of treatment. The objectives of this study were to determine the
Human interleukin 2 (IL-2) promotion of immune regulation and clinical outcomes: a review
Capobianco MP, et al.
Journal of Cytokine Biology, 1, 109-109 (2016)
Michael J Molloy et al.
Journal of immunology (Baltimore, Md. : 1950), 182(8), 4512-4515 (2009-04-04)
There is an urgent need to develop novel therapies for controlling recurrent virus infections in immune suppressed patients. Disease associated with persistent gamma-herpesvirus infection (EBV, HHV-8) is a significant problem in AIDS patients and transplant recipients, and clinical management of



Global Trade Item Number

SKUGTIN
I17002-10UG04061833180716